Amanote Research

Amanote Research

    RegisterSign In

Erratum: Funding Crunch Forces Stem Cell Company to Abandon Therapies

Nature Biotechnology - United Kingdom
doi 10.1038/nbt1207-1488a
Full Text
Open PDF
Abstract

Available in full text

Categories
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
Date

December 1, 2007

Authors
Monya Baker
Publisher

Springer Science and Business Media LLC


Related search

Funding Crunch Forces Stem Cell Company to Abandon Therapies

Nature Reports Stem Cells
2007English

Stem Cell Therapies on Pancreatitis

2015English

Genome Canada Cancels Stem-Cell Project Funding

Nature
Multidisciplinary
2009English

Stem Cell Therapies Benefit Alport Syndrome

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2009English

Stem Cell–directed Therapies in Pancreatic Cancer

Current Problems in Cancer
Cancer ResearchOncology
2013English

Experimental Treatments: Regulating Stem-Cell Therapies Worldwide

Nature
Multidisciplinary
2013English

Stem Cell Therapies for Spinal Cord Injury

Nature Reviews Neurology
Molecular NeuroscienceNeurologyCellular
2010English

A Strategy Using Pluripotent Stem Cell-Derived Hepatocytes for Stem Cell-Based Therapies

2011English

Developing Stem Cell-Based Therapies for Neural Repair

Frontiers Research Topics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy